AR100745A1 - Nanopartículas de quitosano cargadas con antígeno para inmunoterapia - Google Patents
Nanopartículas de quitosano cargadas con antígeno para inmunoterapiaInfo
- Publication number
- AR100745A1 AR100745A1 ARP150101789A ARP150101789A AR100745A1 AR 100745 A1 AR100745 A1 AR 100745A1 AR P150101789 A ARP150101789 A AR P150101789A AR P150101789 A ARP150101789 A AR P150101789A AR 100745 A1 AR100745 A1 AR 100745A1
- Authority
- AR
- Argentina
- Prior art keywords
- antigen
- nanoparticles
- quitosane
- immunotherapy
- nanoparticles loaded
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14001974 | 2014-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR100745A1 true AR100745A1 (es) | 2016-10-26 |
Family
ID=50897334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150101789A AR100745A1 (es) | 2014-06-06 | 2015-06-05 | Nanopartículas de quitosano cargadas con antígeno para inmunoterapia |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10369217B2 (enExample) |
| EP (1) | EP3151856B1 (enExample) |
| JP (1) | JP6730937B2 (enExample) |
| CN (1) | CN106456746B (enExample) |
| AR (1) | AR100745A1 (enExample) |
| AU (1) | AU2015271295B2 (enExample) |
| CA (1) | CA2951063C (enExample) |
| ES (1) | ES2754507T3 (enExample) |
| IL (1) | IL249357B (enExample) |
| WO (1) | WO2015185180A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3698773A1 (en) | 2019-02-21 | 2020-08-26 | Università degli Studi di Parma | Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination |
| CN110974805A (zh) * | 2019-12-23 | 2020-04-10 | 中国科学院海洋研究所 | 具有增强抗原提呈细胞提呈抗原作用的壳聚糖衍生物纳米粒及制备 |
| GB202018665D0 (en) * | 2020-11-26 | 2021-01-13 | Provost Fellows And Scholars Of Trinity College Dublin | Immunotherapy for cancer |
| WO2023168541A1 (en) * | 2022-03-09 | 2023-09-14 | Shenzhen Genius Biotech Service Co., Ltd. | Chitosan nanoparticles (cnps) and preparation method thereof |
| WO2024083221A1 (zh) * | 2022-10-21 | 2024-04-25 | 北京安必奇生物科技有限公司 | 一种黏膜给药制剂及其制备方法和应用 |
| CN117379393A (zh) * | 2023-10-11 | 2024-01-12 | 北京安必奇生物科技有限公司 | 一种核酸药物黏膜给药制剂及其制备方法和应用 |
| CN119506406A (zh) * | 2023-08-24 | 2025-02-25 | 康希诺生物股份公司 | 一种表征吸入疫苗性能的方法 |
| CN117398482B (zh) * | 2023-09-18 | 2026-04-24 | 浙江理工大学 | 一种卵清蛋白负载硝基自由基氮氧化物纳米复合材料及其制备方法和应用 |
| WO2025209535A1 (en) * | 2024-04-03 | 2025-10-09 | Suzhou Xinxin Biopharma Co., Ltd | Compositions and associated methods for chitosan-based nano-carriers for therapeutic agents and their applications |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100638041B1 (ko) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
| US8137697B1 (en) * | 2004-10-05 | 2012-03-20 | Gp Medical, Inc. | Nanoparticles for protein/peptide delivery and delivery means thereof |
| ES2259914B1 (es) * | 2005-03-14 | 2007-06-16 | Advanced In Vitro Cell Technologies, S.L. | Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas. |
| EP2397123A1 (en) * | 2006-07-07 | 2011-12-21 | Aarhus Universitet | Nanoparticles for nucleic acid delivery |
| WO2008039390A2 (en) * | 2006-09-22 | 2008-04-03 | Government Of The Usa., Dept. Of Health & Human Services | Compositions and methods for chitosan enhanced immune response |
| WO2010001932A1 (ja) * | 2008-07-01 | 2010-01-07 | 日東電工株式会社 | 表面被覆微粒子の医薬組成物 |
| CN107875127A (zh) * | 2012-02-28 | 2018-04-06 | 艾塞尤提卡控股公司 | 可吸入药物组合物 |
-
2015
- 2015-05-12 EP EP15722448.6A patent/EP3151856B1/en active Active
- 2015-05-12 ES ES15722448T patent/ES2754507T3/es active Active
- 2015-05-12 WO PCT/EP2015/000974 patent/WO2015185180A1/en not_active Ceased
- 2015-05-12 AU AU2015271295A patent/AU2015271295B2/en active Active
- 2015-05-12 CN CN201580030088.4A patent/CN106456746B/zh active Active
- 2015-05-12 JP JP2016571251A patent/JP6730937B2/ja active Active
- 2015-05-12 US US15/316,709 patent/US10369217B2/en active Active
- 2015-05-12 CA CA2951063A patent/CA2951063C/en active Active
- 2015-06-05 AR ARP150101789A patent/AR100745A1/es unknown
-
2016
- 2016-12-04 IL IL249357A patent/IL249357B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL249357A0 (en) | 2017-02-28 |
| EP3151856B1 (en) | 2019-08-07 |
| AU2015271295B2 (en) | 2020-04-16 |
| US10369217B2 (en) | 2019-08-06 |
| EP3151856A1 (en) | 2017-04-12 |
| JP2017516834A (ja) | 2017-06-22 |
| CN106456746A (zh) | 2017-02-22 |
| IL249357B (en) | 2021-01-31 |
| CA2951063A1 (en) | 2015-12-10 |
| WO2015185180A1 (en) | 2015-12-10 |
| CA2951063C (en) | 2022-10-04 |
| JP6730937B2 (ja) | 2020-07-29 |
| ES2754507T3 (es) | 2020-04-17 |
| AU2015271295A1 (en) | 2017-01-19 |
| US20170143822A1 (en) | 2017-05-25 |
| CN106456746B (zh) | 2021-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201908550T4 (tr) | Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi. | |
| CY1124979T1 (el) | Κατασκευασματα πρωτεϊνης uspa2 και χρησεις αυτων | |
| BR112017008165A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
| MX2017005344A (es) | Composiciones y metodos para reforzar la eficacia de inmunoterapia celular adoptiva. | |
| CR20200409A (es) | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la misma terapia contra el cáncer epitelial de ovario y otros tipos de cáncer (divisional 2018-0027). | |
| CL2018000232A1 (es) | Mezcla de péptidos (divisional solicitud 201601405) | |
| EA201691478A1 (ru) | Новый полисахарид и его применения | |
| WO2014113490A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
| EA201790248A1 (ru) | Композиции носитель-антитело и способы их получения и применения | |
| EA201692425A1 (ru) | Модифицированные биополимеры и способы их получения и использования | |
| EA201790294A1 (ru) | Средства на основе флагеллина и применения, включающие эффективную вакцинацию | |
| ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
| EA201790265A1 (ru) | Способы получения тромбоцит-содержащих продуктов | |
| EA201590829A1 (ru) | Новые мукозные адъюванты и системы доставки | |
| MX387421B (es) | Producción de virus en huevos aviares. | |
| MX377258B (es) | Composiciones de vectores poxvirus y su uso para inducir una respuesta inmunitaria. | |
| PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| MD20150109A2 (ro) | Construcţii proteice mitocondriale şi utilizările acestora | |
| EP3166617C0 (en) | ELEMENT-FREE POLOXAMER COMPOSITION WITH EXTENDED CIRCULATION LIFE, METHODS OF PRODUCTION AND USES | |
| TN2014000518A1 (en) | Reassortant btv and ahsv vaccines | |
| EP3939604A3 (en) | Influenza hemagglutinin protein vaccines | |
| EA201991702A1 (ru) | Самосборные белковые наночастицы, инкапсулирующие иммуностимулирующие нуклеиновые кислоты | |
| MX385886B (es) | Macromoleculas estrellas compatibles con tensoactivos. | |
| MX363149B (es) | Vacunas de nucleoproteina de la influenza. | |
| BR112016012838A2 (pt) | Composição para a administração oral de um agente bioativo incluindo partículas que compreendem um agente bioativo e um polímero mucoadesivo em uma solução aquosa, e, método de preparação da composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |